TRAb Test: TSH-Receptor Antibodies (and TSI) Explained

The TRAb test measures TSH-receptor antibodies — autoantibodies your immune system makes, by mistake, against the TSH receptor on the surface of your thyroid gland. What makes them unusual is that most of them stimulate that receptor, the way the pituitary hormone TSH normally does, so the thyroid revs up and pours out too much hormone. That is why TRAb are the near-specific marker of Graves' disease, the leading cause of an overactive thyroid (hyperthyroidism). Where TPO antibodies point mainly toward Hashimoto's and an underactive thyroid, TRAb point toward autoimmune hyperthyroidism. This guide explains the confusing family of names — TRAb, TSI, and TBII — the IU/L cutoffs, why the test matters so much in pregnancy, and how to read a positive or negative result. TRAb are one of the antibody tests that round out the thyroid panel.

Key takeaways

• TRAb are autoantibodies aimed at the TSH receptor. Most of them stimulate the thyroid and drive hyperthyroidism, which is why they define Graves' disease.¹²
• The result is read mainly as positive or negative. The cutoff is assay-dependent and reported in IU/L — a common threshold is around 1.75 IU/L (some assays ~1.0). Trust the range on your report.³
• A positive TRAb is near-specific for Graves' disease: with modern assays, sensitivity and specificity both exceed 97%.⁴
• Three main uses: confirm that a case of hyperthyroidism is autoimmune, guide pregnancy (TRAb cross the placenta), and help predict relapse after antithyroid drug therapy.²⁵
• TRAb, TSI, and TBII describe overlapping tests: TBII (binding) and TSI (stimulating bioassay) are two ways of detecting the same underlying antibodies.⁴
• You don't treat an antibody number — you treat the hyperthyroidism, if present, at a clinician-set dose. TRAb are always read with TSH and Free T4.⁶

What are TSH-receptor antibodies (TRAb)?

Start with normal thyroid control. The pituitary gland makes TSH (thyroid-stimulating hormone), which docks onto a TSH receptor on the surface of thyroid cells. That signal tells the thyroid how much hormone — T4 and T3 — to make, and a feedback loop keeps it balanced.

In some people, the immune system produces antibodies aimed at that receptor: TSH-receptor antibodies, or TRAb. In the great majority of cases (Graves' disease), these antibodies mimic TSH: they bind the receptor and switch it on continuously, ignoring the feedback brake. The thyroid runs wild and makes too much hormone — that is hyperthyroidism.² Because they target one of the body's own structures, this is an autoimmune disease.

Less often, some TRAb block the receptor instead of stimulating it, which can contribute to an underactive thyroid — one more reason the result is never read alone but always alongside TSH and Free T4.¹

TRAb vs TSI vs TBII

The naming is genuinely confusing. All three terms refer to antibodies against the same TSH receptor; they differ in how the lab detects them.⁴⁷

• TRAb (TSH-receptor antibodies) is the umbrella term for any antibody that binds the TSH receptor — stimulating, blocking, or neutral. When a lab reports "TRAb," it usually means a binding assay.
• TBII (thyrotropin-binding inhibitor immunoglobulin) is that binding assay. It measures whether antibodies attach to the receptor and displace TSH, but it does not distinguish stimulating from blocking antibodies. Most routine "TRAb" results come from a TBII-type assay, reported in IU/L.
• TSI (thyroid stimulating immunoglobulin) is a functional bioassay: it measures whether the antibodies actually turn the receptor on, so it is more specific for the stimulating antibodies of Graves' disease.

In practice, a modern third-generation TRAb/TBII assay is highly accurate and is what most clinicians order first. A TSI bioassay may be added when telling stimulating from blocking activity matters — for example in pregnancy or thyroid eye disease.²⁷⁸ For everyday diagnosis of Graves', a positive TRAb and a positive TSI carry the same message.

Why the test is done

Your clinician may order a TRAb test in three main situations:²⁵

• Confirm the cause of hyperthyroidism. When TSH is low and Free T4 is high, a positive TRAb confirms Graves' disease and often spares you further imaging such as a radioactive iodine uptake scan.¹⁹
• Guide a pregnancy in someone who has, or has had, Graves' disease. High TRAb can cross the placenta and stimulate the baby's thyroid, so measurement is recommended at specific points (see below).¹⁰
• Help predict relapse. After a course of antithyroid drugs, a still-elevated TRAb signals a higher chance of recurrence, which shapes the decision to continue medication or move to definitive treatment.²

By contrast, when the picture is an underactive thyroid (high TSH), the antibody to look for is TPO antibodies, not TRAb.

How the test is done

The TRAb test is an ordinary blood draw from a vein in your arm, usually taken with TSH and Free T4 so the whole thyroid picture can be read together. Fasting is not required — these antibodies don't change with meals.³

One caution: high-dose biotin (vitamin B7, found in many "hair, skin and nails" supplements) can interfere with the immunoassay chemistry used for thyroid tests. Stop biotin for a few days before testing, per your lab's guidance, and tell your clinician you take it.²

Normal ranges / interpreting a positive result

Here are indicative adult reference points. The key idea: there is no universal number, because the cutoff depends entirely on the assay your lab uses. Think in terms of positive vs negative first.

Good to know: the usual unit is IU/L (international units per liter). The positivity cutoff varies by method, so the same sample can read "borderline" on one platform and "negative" on another. Rely on the positive/negative call and the interval on your report, not a threshold found online. Unlike TPO antibodies, a positive TRAb is uncommon in healthy people, which is what makes it so specific for Graves' disease.⁴

TRAb are never read alone — always cross them with TSH and Free T4, which show how the thyroid is actually functioning.

A positive or elevated TRAb

A positive TRAb in the usual setting of hyperthyroidism (low TSH, high Free T4) confirms Graves' disease — the number-one cause of an overactive thyroid, especially in younger women.⁶ The antibodies stimulate the TSH receptor and the thyroid overshoots. Possible signs include palpitations, weight loss, anxiety, tremor, heat intolerance, sometimes a goiter, or eye involvement (see below).

With modern second- and third-generation assays the test performs extremely well: sensitivity around 97% and specificity around 98–99% for Graves' disease. A positive result makes Graves' very likely, and a negative result makes it unlikely — which lets clinicians settle the cause of hyperthyroidism quickly, often without a scan.⁴²

Does the level matter? For diagnosis, mostly the positive/negative call counts. But the height of the value genuinely matters in two settings: during pregnancy (higher level, greater risk to the baby) and for predicting relapse at the end of drug treatment.⁵

A negative TRAb

A negative TRAb in someone with hyperthyroidism points to a cause other than Graves': a hyperfunctioning nodule or toxic goiter, a transient thyroiditis (temporary inflammation, sometimes postpartum), or excess thyroid hormone intake. The clinician then leans on other tests such as ultrasound or a radioactive iodine uptake scan. A negative result is not a failure — it's a normal part of narrowing down the diagnosis.⁶¹¹

TRAb in Graves' disease

Graves' disease is an autoimmune condition in which stimulating TRAb keep the thyroid switched on. Beyond the thyroid itself, two features are worth knowing.

Predicting relapse. In Graves', antithyroid drug therapy is often given for 12 to 18 months. After stopping, roughly half of people relapse. TRAb help anticipate this: a level still high at the end of treatment is linked to a higher chance of recurrence, while TRAb that have turned negative are more reassuring.²⁵ This isn't a verdict — it's one input that helps you and your clinician choose between continuing medication and moving to definitive treatment (radioactive iodine or surgery).

Thyroid eye disease. Graves' can come with thyroid eye disease (Graves' orbitopathy) — bulging eyes (proptosis), redness, or double vision. TRAb are detectable in more than 95% of these patients, and the level tracks with how active the eye disease is.¹²

TRAb vs TPO antibodies

The two thyroid autoantibodies are easy to confuse. The distinction is simple and useful:

TPO antibodies can also be positive in Graves', but it's the TRAb that confirm the diagnosis. A panel can show both positive — that just reinforces the autoimmune picture. Either way, it's TSH and Free T4 that tell you how the gland is actually working.²

TRAb in pregnancy

This is one of the most important reasons to measure TRAb. TSH-receptor antibodies are IgG-class immunoglobulins, so they can cross the placenta. In someone with Graves' disease — including someone whose thyroid was treated with surgery or radioactive iodine but who still carries TRAb — these antibodies can reach the fetal bloodstream and stimulate the baby's thyroid, risking fetal or neonatal hyperthyroidism.⁵

That is why the American Thyroid Association recommends measuring TRAb in pregnant people with a current or past history of Graves' disease, at defined points in pregnancy. The level helps estimate the risk to the baby and, when needed, triggers fetal ultrasound surveillance and monitoring of the newborn.¹⁰ If this applies to you, your clinician — usually with an endocrinologist and the obstetric team — sets the schedule and the plan.

After delivery. Hyperthyroidism appearing in the months after birth can be postpartum Graves' disease or a postpartum thyroiditis (unrelated to TRAb). TRAb are typically positive in Graves' and negative in thyroiditis, so the test helps tell apart two conditions managed very differently.¹¹

Factors and limitations

Several things change the likelihood of a positive TRAb or how it's interpreted: female sex and age (Graves' is more common in younger women), a personal or family history of autoimmunity, smoking (a driver of Graves' and eye disease), pregnancy and the postpartum period, and certain medications (amiodarone, lithium, cancer immunotherapies). Biotin supplements can also interfere with the assay. Two limits matter: the cutoff is assay-dependent, so values aren't comparable between labs, and a binding assay (TBII) does not separate stimulating from blocking antibodies — a TSI bioassay may be needed for that. Always share your history, smoking status, and medications.⁶²

When to see a doctor

See a clinician if you have symptoms of an overactive thyroid — palpitations, unexplained weight loss, anxiety, tremor, heat intolerance, or eye changes such as bulging or double vision — or if a TRAb result comes back positive. It is especially important to seek advice before or early in pregnancy if you have, or have ever had, Graves' disease, because TRAb monitoring protects the baby. A positive TRAb is not an emergency and Graves' disease is very treatable. Seek urgent care for a very fast or irregular heartbeat, high fever, confusion, or sudden vision changes.

Recent research

According to recent publications indexed on PubMed:

• A test now central to diagnosing Graves'. A major update stresses that stimulating TRAb are a specific biomarker of Graves' disease, offering a fast, reliable way to establish the autoimmune cause of hyperthyroidism and to guide treatment — antithyroid drugs, radioactive iodine, or surgery.²
• High diagnostic accuracy, confirmed. A systematic review and meta-analysis of second- and third-generation assays found sensitivity around 97% and specificity around 97–99% for Graves' disease, supporting broad use of the test.⁴
• In pregnancy, a test that anticipates risk to the baby. Recent reviews confirm that TRAb predict fetal and neonatal hyperthyroidism and are built into the management of Graves' disease during pregnancy and before conception.⁵
• Eye disease: a targeted option. The pivotal OPTIC trial showed that teprotumumab, an antibody against the IGF-1 receptor, markedly reduced proptosis and improved quality of life in active thyroid eye disease — reserved for moderate-to-severe cases given its cost and side effects.¹³¹²

These findings concern diagnosis, monitoring, and management; they do not authorize any self-treatment and do not replace your clinician's advice.

Get your TRAb interpreted by AI DiagMe

TRAb are never read alone: their meaning depends on your TSH, your Free T4, any pregnancy, your history, and how the number trends over time (see the thyroid panel). That cross-reading is what gives the result its true value.

👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole context into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.

Frequently asked questions

Bottom line

The TRAb test measures TSH-receptor antibodies — autoantibodies that usually stimulate the thyroid, making them the near-specific marker of Graves' disease, the leading cause of hyperthyroidism. Read the result as positive vs negative (cutoff assay-dependent, often < 1.75 IU/L), remember that TSI and TBII are just two ways of detecting the same antibodies, and know that a positive TRAb confirms autoimmune hyperthyroidism, is invaluable in pregnancy (the antibodies cross the placenta), and helps predict relapse after treatment. TRAb differ from TPO antibodies, which lean toward Hashimoto's. You don't treat an antibody number — you treat the hyperthyroidism, under a clinician's care. No value is read alone: it's your full set of markers, read together with TSH and Free T4 in the thyroid panel, that makes sense of it — exactly what AI DiagMe does, alongside your physician.

Sources

Official U.S. sources and peer-reviewed publications (PubMed) used for this guide: